Centessa Pharmaceuticals plc Quarterly Debt-to-equity in % from Q1 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Centessa Pharmaceuticals plc quarterly Debt-to-equity history and growth rate from Q1 2022 to Q2 2024.
Centessa Pharmaceuticals plc Debt-to-equity for the quarter ending June 30, 2024 was 46.8 %, a 35.5% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	46.8	+12.3	+35.5%	Jun 30, 2024
Q1 2024	47.7	+17.8	+59.3%	Mar 31, 2024
Q4 2023	44	+18.1	+69.6%	Dec 31, 2023
Q3 2023	38.9	+13.5	+53.3%	Sep 30, 2023
Q2 2023	34.5	+13.7	+65.7%	Jun 30, 2023
Q1 2023	30	+12.8	+74.7%	Mar 31, 2023
Q4 2022	26			Dec 31, 2022
Q3 2022	25.4			Sep 30, 2022
Q2 2022	20.8			Jun 30, 2022
Q1 2022	17.2			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.